SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as investors aggressively discuss its volatility and potential for explosive gains, with many participants actively debating whether the meme coin will replicate its past momentum or fall victim to typical pump-and-dump market cycles. The community remains highly polarized, oscillating between excitement over potential breakout moves and cautionary warnings regarding the high-risk nature of the asset.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending due to heightened community speculation surrounding a potential supply shock, upcoming exchange burns, and ongoing legal developments. Investors are actively discussing the possibility of a major recovery, with many sharing long-term price predictions and strategies for navigating market volatility.

TerraClassicUSD (USTC) was originally launched as an algorithmic stablecoin within the Terra ecosystem, designed to maintain a peg to the US dollar through an automated market-Module mechanism with LUNA (now LUNC). However, following the collapse of the Terra ecosystem in May 2022, the core stabilizing mechanism was disabled, and USTC lost its peg to the US dollar.  Since then, USTC has been a freely traded digital asset, with its price determined purely by market supply and demand. It no longer functions as a stablecoin, nor does it have an active peg-maintenance mechanism.  USTC remains an integral part of the Terra Classic ecosystem, where it continues to be used for various purposes, including DeFi applications , gas fees and trading. Unlike traditional fiat-backed assets, USTC’s value fluctuates based on market conditions and community participation.

TerraClassicUSD

TerraClassicUSD is gaining momentum as investors react to ongoing ecosystem governance proposals, active token burn initiatives, and optimistic speculation regarding a potential repeg. The community is closely monitoring legal developments and potential regulatory shifts, with many traders focused on volume-driven price movements and increased staking activity within the broader Terra Luna ecosystem.

LUNA is the native token of the Terra blockchain, a decentralized platform designed to host applications and provide financial tools. Following a transition from Terra Classic, the new Terra chain was established through a community-led governance proposal to focus on a decentralized economy without a stablecoin. As the foundational asset of the protocol, LUNA functions as the engine for the network where value moves as users pay gas fees to interact with decentralized applications. Its primary value proposition lies in its ability to scale rewards for stakers as developer activity and transaction volumes grow within the ecosystem.  The network maintains security through a Proof of Stake system using the Tendermint consensus mechanism, where 130 independent validators compare transactions to ensure the integrity of the blockchain. Users who do not want to run their own node can delegate their tokens to these validators to help record and verify data. To ensure accountability, the protocol employs slashing, a penalty that removes a small portion of staked tokens if a validator misbehaves or goes offline.  Originally created by Terraform Labs, the project has evolved into a community-governed model where independent developer groups and users maintain the protocol. Terraform Labs currently manages a claims portal for users impacted by previous network events as part of ongoing legal and bankruptcy proceedings. The token serves multiple roles, including paying for gas fees to interact with dApps , providing voting power for governance proposals , and earning rewards through a fixed 7% annual inflation rate.

Terra 2.0

Terra 2.0 (LUNA) is currently sparking intense debate within the crypto community, driven by ongoing legal developments surrounding the founder and speculation regarding the project's long-term viability. Investors remain polarized, with some closely monitoring potential governance and ecosystem upgrades while others express skepticism, often drawing comparisons to past market volatility and drawing parallels to Terra Classic (LUNC).

ProShares Trust - ProShares Ultra 7-10 Year Treasury 2x Shares

ProShares Ultra 7-10 Year Treasury

ProShares Ultra 7-10 Year Treasury (UST) is seeing active discussion as investors weigh its role in macro hedging against broader bond market volatility and central bank policy uncertainty. Community sentiment remains split, with traders monitoring how shifting interest rates and evolving fiscal conditions impact the ETF's performance relative to other safe-haven assets.

Axelar delivers secure interchain communication. That means dApp users can interact with any asset, any application, on any chain, with one click. You can think of it as Stripe for Web3. Developers interact with a simple API atop a permissionless network that routes messages and ensures network security via proof-of-stake consensus.  Axelar is a blockchain that connects blockchains. To do this securely, Axelar network uses proof-of-stake consensus. Network validators produce new blocks, participate in multiparty signing and vote on external chain states. Tokenholders stake the AXL token, delegating tokens to a validator’s staking pool and receiving rewards, minus the validator’s commission.  The AXL token is used for governance and to pay network transaction fees to validators and tokenholders. However, users of the Axelar network do not need to hold the token. Conversions into AXL tokens and destination-chain tokens are handled on the back end, so that users need only pay gas once, in the source-chain token.  Axelar network rewards are “inflationary” — they increase the total supply of AXL — but there is potential for supply to become deflationary based on the transaction fee mechanic described above.

Axelar

Axelar is capturing community attention following the launch of a new XRPL EVM sidechain integration, which investors view as a pivotal step in expanding the network's utility. While some holders express frustration over recent price volatility and token dilution concerns, many remain focused on the project's long-term interoperability potential and its role in connecting major blockchain ecosystems.

JPMorgan Chase & Co. is a financial holding company, which engages in the provision of financial and investment banking services. The firm focuses on investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing, and asset management. It operates through the following segments: Consumer and Community Banking (CCB), Commercial and Investment Bank (CIB), Asset and Wealth Management (AWM), and Corporate. The CCB segment originates and services mortgage loans. The CIB segment makes markets and services clients across fixed income, foreign exchange, equities, and commodities. The AWM segment provides initial capital investments in products such as mutual funds and capital invested alongside third-party investors. The Corporate segment manages its liquidity, funding, capital, structural interest rate, and foreign exchange risks. The company was founded in 1799 and is headquartered in New York, NY.

JPMorgan Chase & Co.

JPMorgan Chase & Co

JPMorgan Chase is trending as investors digest the bank's latest earnings results and monitor Jamie Dimon's cautious outlook regarding rising global geopolitical tensions and complex risks. The stock is a primary focus for the community as they weigh institutional commentary on credit quality and interest rate guidance against broader macro uncertainty.

The Mullen Army Token originated from a dedicated community of retail investors who faced challenges in the traditional stock market. We united to create a cryptocurrency that embodies our principles and aspirations for a fair financial system.     We provide a platform for retail investors to engage in a transparent and fair financial market. Our efforts include grassroots marketing, community engagement, and educational content to empower our investors.

MullenArmy

MullenArmy-associated crypto assets are facing intense community division as investors clash over the project's legitimacy, with supporters promoting potential rebounds while detractors warn of persistent pump-and-dump patterns linked to past stock market controversies. The discourse remains highly polarized, centered on accusations of deceptive tactics, dilution concerns, and a cycle of retail losses mirroring the volatility of the related EV company.

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307. The company was founded by John C. Klock, Christopher M. Starr and Grant W. Denison on March 21, 1997, and is headquartered in San Rafael, CA.

Biomarin Pharmaceutical Inc. - Registered Shares

BioMarin shares are under pressure as the market reacts to competitive Phase 3 data from Ascendis Pharma, fueling concerns over the long-term dominance of BioMarin's achondroplasia treatment, Voxzogo. Despite the volatility, many investors are viewing the pullback as an oversold buying opportunity, highlighting BioMarin's strong revenue growth, solid pipeline, and the recent involvement of activist investor Elliott Management.

Perma-Pipe International Holdings, Inc. engages in the design, manufacture, and sale of specialty piping and leak detection systems. Its products include industrial and secondary containment piping systems for transporting chemicals, hazardous fluids and petroleum products, insulated and jacketed district heating and cooling piping systems for efficient energy distribution to multiple locations from central energy plants, and the coating and/or insulation of oil and gas gathering flow and long lines for oil or mineral transportation. The company was founded on October 12, 1993 and is headquartered in The Woodlands, TX.

Perma-Pipe International Holdings Inc

Perma-Pipe International Holdings is gaining traction as investors highlight its role in critical infrastructure projects, particularly involving AI-enabled data centers and energy expansion in the Middle East. The community is actively discussing the company's strong project awards and potential for upward rerating, with many focusing on long-term accumulation despite recent sector-wide volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Mineralys Therapeutics (MLYS) Projected to Post Earnings on Wednesday

Mineralys Therapeutics (NASDAQ:MLYS) will be releasing its Q1 2026 earnings after the market closes on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-mineralys-therapeutics-inc-stock...

Mineralys Therapeutics (NASDAQ:MLYS) Trading 8.2% Higher   - Should You Buy?

Mineralys Therapeutics (NASDAQ:MLYS) Stock Price Up 8.2% - Should You Buy...

Mineralys Therapeutics, Inc. $MLYS Shares Bought by Jennison Associates LLC

Jennison Associates LLC grew its holdings in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 234.4% in the fourth quarter, according to its most recent filing with the...

Pictet Asset Management Holding SA Sells 76,286 Shares of Mineralys Therapeutics, Inc. $MLYS

Pictet Asset Management Holding SA trimmed its stake in shares of Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Free Report) by 8.2% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 852,883 shares of the...

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down - Here's Why

Mineralys Therapeutics (NASDAQ:MLYS) Shares Gap Down - Here's What Happened...

Insider Selling: Mineralys Therapeutics (NASDAQ:MLYS) Insider Sells 416 Shares of Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 416 shares of the business's stock in a transaction that occurred on Friday, April 17th. The shares were...

David Malcom Rodman Sells 416 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 416 shares of the stock in a transaction dated Friday, April 17th. The stock was sold at an average price...

David Malcom Rodman Sells 6,348 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 6,348 shares of Mineralys Therapeutics stock in a transaction dated Wednesday, April 15th. The shares...

Mineralys Therapeutics (NASDAQ:MLYS) CEO Sells $422,035.90 in Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) CEO Jon Congleton sold 15,730 shares of Mineralys Therapeutics stock in a transaction that occurred on Monday, April 13th. The stock was...

David Malcom Rodman Sells 14,058 Shares of Mineralys Therapeutics (NASDAQ:MLYS) Stock

Mineralys Therapeutics, Inc. (NASDAQ:MLYS - Get Free Report) insider David Malcom Rodman sold 14,058 shares of the stock in a transaction dated Monday, April 13th. The stock was sold at an average...

Mineralys Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing medicines to target diseases driven by abnormally elevated aldosterone. Its clinical-stage product candidate, lorundrostat, is a proprietary, orally administered, highly selective aldosterone synthase inhibitor that are initially developing for the treatment of cardiorenal conditions affected by abnormally elevated aldosterone, including hypertension and chronic kidney disease. The company was founded by Brian Taylor Slingsby on May 31, 2019 and is headquartered in Radnor, PA.

MLYS
Mineralys Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest MLYS News

MLYSMineralys Therapeutics Inc